RMR Wealth Builders’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

RMR Wealth Builders’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-40,250	Closed	-$63K	–	198
2022 Q3	$63K	Buy	40,250 +15,750	+64%	+$35.7K	0.02%	193
2022 Q2	$49K	Buy	+24,500	New	+$42.4K	0.01%	193
2021 Q2	–	Sell	-300	Closed	-$2K	–	768
2021 Q1	$2K	Buy	+300	New	+$3.17K	﹤0.01%	743
2020 Q4	–	Sell	-10,300	Closed	-$115K	–	564
2020 Q3	$115K	Buy	+10,300	New	+$94.3K	0.03%	208

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

RMR Wealth Builders's SRNE Position: Q4 2022 in Review

RMR Wealth Builders sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 40,250 shares — an estimated $63K sold.

RMR Wealth Builders first reported a position in SRNE in Q3 2020 and held it in 4 quarters. The position peaked at $115K in Q3 2020. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

RMR Wealth Builders reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
RMR Wealth Builders sold 40,250 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $63K.
RMR Wealth Builders first reported a position in Sorrento Therapeutics, Inc. in Q3 2020 and held it in 4 quarters.
RMR Wealth Builders's Sorrento Therapeutics, Inc. position peaked at $115K in Q3 2020.
221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on RMR Wealth Builders's 13F filing for Q4 2022, filed 2 Feb 2023.